In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L’Oréal To Expand Professionnel Portfolio With ARTec Acquisition

This article was originally published in The Rose Sheet

Executive Summary

L'Oréal USA will broaden its Professionnel salon business with the acquisition of ARTec Systems Group, a range of professional hair and body care lines, L'Oréal announced Aug. 20

You may also be interested in...



Marketing In Brief

Orlane: B21 Les Fluidratants moisturizers will be promoted with distribution of approximately 50,000 brochure mailers with sample, as well as deluxe samples at counter, Parisian firm says. Orlane will distribute additional 75,000-100,000 mailers in the spring. Line features Crème Fluidrants and Mousse Fluidratante, which contain hydrating water plants extract made of bamboo pith, lotus flower and water lily. Available now in 35 Saks Fifth Avenue and 20 Neiman Marcus doors, items will roll out to full 110-door U.S. distribution, including Bloomingdale's and specialty stores in January, firm says. Crème retails for $150 for 1.7 oz. pump bottle, while Mousse costs $75 for 2.5 oz. aerosol spray...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010556

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel